Cell Receptor Inc. holds patents on a new method for well-tolerated prevention of cancer metastases, an unmet need.  Metastases cause 90% of cancer deaths. Our findings allow for the first time to target a function governing all cell proliferation, that is located upstream of well known RTKs.

 

Location

Route de Chêne 30A, 1208 Genève, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business